Corrigendum to "Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings" [Obes. Pillars, Volume 11, September 2024, 100112].

Autor:	Gala K; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Ghusn W; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Brunaldi V; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., McGowan C; True You Weight Loss, Cary, NC, USA., Sharaiha RZ; Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, USA., Maselli D; True You Weight Loss, Cary, NC, USA., Vanderwel B; Eviva, Shoreline, WA, USA., Kedia P; Methodist Dallas Medical Center, Dallas, TX, USA., Ujiki M; NorthShore University Health System, Evanston, IL, USA., Wilson E; University of Texas Health Science Center - Houston, Houston, TX, USA., Vargas EJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Storm AC; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Abu Dayyeh BK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Jazyk:	angličtina
Zdroj:	Obesity pillars [Obes Pillars] 2024 Jun 29; Vol. 11, pp. 100116. Date of Electronic Publication: 2024 Jun 29 (Print Publication: 2024).
DOI:	10.1016/j.obpill.2024.100116
Abstrakt:	[This corrects the article DOI: 10.1016/j.obpill.2024.100112.]. (© 2024 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu